HCN2 ‐Associated Neurodevelopmental Disorders: Data from Patients and Xenopus Cell Models
Annals of Neurology · 2025-09 · 98 (3) · 573-589
DOI: 10.1002/ana.27277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 05.06.2025. Verfasst von Clara Houdayer und 52 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Angers University Hospital, Angers, France. Hauptthemen laut MEDLINE: Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels, Neurodevelopmental Disorders, Potassium Channels. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHGRI NIH HHS.
Abstract (Originalsprache)
Objective
We aimed to characterize the phenotypic spectrum and functional consequences associated with variants in HCN2 , encoding for the hyperpolarization‐activated cyclic nucleotide (HCN) gated channel 2.
Methods
GeneMatcher facilitated the recruitment of 21 individuals with HCN2 variants from 15 unrelated families, carrying HCN2 variants. In vitro functional studies were performed by electrophysiology with Xenopus laevis oocytes and membrane trafficking was investigated in HEK cells by confocal imaging. Structural 3D‐analysis of the HCN2 variants was performed.
Results
The phenotypic spectrum included developmental delay/intellectual disability (DD/ID, 17/21), epilepsy (10/21), language disorders (16/21), movement disorders (12/21), and axial hypotonia (10/21). Thirteen pathogenic variants (12 new and 1 already described) were identified: 11 missense (8 monoallelic and 3 biallelic), 1 recurrent inframe deletion (monoallelic), and 1 frameshift (biallelic). Functional analysis of p.(Arg324His) variant showed a strong increase of HCN2 conductance, whereas p.(Ala363Val) and p.(Met374Leu) exhibited dominant negative effects. The p.(Leu377His), p.(Pro493Leu), and p.(Gly587Asp) variants rendered HCN2 electrophysiologically silent and impaired membrane trafficking. Structural 3D‐analysis revealed that, except for p.(Arg324His), all variants altered HCN2 stability.
Interpretation
Our findings broadened the HCN2 disease clinical spectrum to include DD/ID with or without epilepsy. Functional analysis in cellular models reveal that pathogenic HCN2 variants can cause either loss‐of‐function or gain‐of‐function, providing critical information for the development of targeted therapies for HCN2 ‐related disorders. ANN NEUROL 2025;98:573–589
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, Angers University Hospital, Angers, France.
- Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
- School of Biosciences, The University of Melbourne, Parkville, Victoria, Australia.
- University of Angers, INSERM, CNRS, MITOVASC, Equipe CarMe, SFR ICAT, Angers, France.
- Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, University College London, London, UK.
- College of Medicine, University of Baghdad, Baghdad, Iraq.
ORCID-Profile: Jennifer Bourreau, Rikke S Møller, Fowzan S Alkuraya, Katherine B Howell, Christian Legros
Förderung
- NHGRI NIH HHS
Zitieren
APA
Houdayer, C., Phillips, A. M., Chabbert, M., Bourreau, J., Maroofian, R., Houlden, H., Richards, K., Saadi, N. W., Dad'ová, E., Van Bogaert, P., Rupin, M., Keren, B., Charles, P., Smol, T., Riquet, A., Pais, L., O'Donnell-Luria, A., VanNoy, G. E., Bayat, A., …, & Legros, C. (2025). HCN2 ‐Associated Neurodevelopmental Disorders: Data from Patients and Xenopus Cell Models. Annals of Neurology, 98(3), 573-589. https://doi.org/10.1002/ana.27277
Vancouver
Houdayer C, Phillips AM, Chabbert M, Bourreau J, Maroofian R, Houlden H, et al. HCN2 ‐Associated Neurodevelopmental Disorders: Data from Patients and Xenopus Cell Models. Annals of Neurology. 2025;98(3):573-589. doi:10.1002/ana.27277
BibTeX
@article{Houdayer2025,
author = {Houdayer, Clara and Phillips, A Marie and Chabbert, Marie and Bourreau, Jennifer and Maroofian, Reza and Houlden, Henry and Richards, Kay and Saadi, Nebal Waill and Dad'ová, Eliška and Van Bogaert, Patrick and Rupin, Mailys and Keren, Boris and Charles, Perrine and Smol, Thomas and Riquet, Audrey and Pais, Lynn and O'Donnell-Luria, Anne and VanNoy, Grace E and Bayat, Allan and Møller, Rikke S and Olofsson, Kern and Jamra, Rami Abou and Syrbe, Steffen and Dasouki, Majed and Seaver, Laurie H and Sullivan, Jennifer A and Shashi, Vandana and Alkuraya, Fowzan S and Poss, Alexis F and Spence, J Edward and Schnur, Rhonda E and Forster, Ian C and Mckenzie, Chaseley E and Simons, Cas and Wang, Min and Snell, Penny and Kothur, Kavitha and Buckley, Michael and Roscioli, Tony and Elserafy, Noha and Dauriat, Benjamin and Procaccio, Vincent and Henrion, Daniel and Lenaers, Guy and Colin, Estelle and Verbeek, Nienke E and Van Gassen, Koen L and Legendre, Claire and Bonneau, Dominique and Reid, Christopher A and Howell, Katherine B and Ziegler, Alban and Legros, Christian},
title = {HCN2 ‐Associated Neurodevelopmental Disorders: Data from Patients and Xenopus Cell Models},
journal = {Annals of Neurology},
year = {2025},
volume = {98},
number = {3},
pages = {573--589},
doi = {10.1002/ana.27277}
}
EUVIMED